Category: 3. Business

  • Black-market oil buyers will push Venezuela for bigger discounts following US seizure – starving Maduro of much-needed revenue

    Black-market oil buyers will push Venezuela for bigger discounts following US seizure – starving Maduro of much-needed revenue

    The U.S. seizure of an oil tanker off the Venezuelan coast looks designed to further squeeze the economy of President Nicolás Maduro’s country.

    The Dec. 10, 2025, operation – in which American forces descended from helicopters onto the vessel – follows months of U.S. military buildup in the Caribbean and was immediately condemned by the Venezuelan government as “barefaced robbery and an act of international piracy.”

    But what exactly is the Trump administraion’s aim in going after the tanker, and how could this impact the already beleaguered economy of Venezuela? The Conversation U.S. turned to Rice University’s Francisco J. Monaldi, an expert on Latin American energy policy, for answers.

    What do we know about the tanker that was seized?

    The seized tanker, which according to reports is a 20-year-old vessel called the Skipper, is a supertanker that can carry around 2 million barrels of oil.

    According to the Trump administration, the vessel was heading to Cuba. But because of the size of the ship, I strongly suspect that the final destination was likely China – tankers the size of the seized one don’t tend to be used to take oil across the Caribbean to Cuba. The ones used for that task are far smaller.

    This particular tanker was sanctioned by the U.S. Treasury in 2022 due to it carrying prohibited Iranian oil. At the time, it was claimed that the ship – then called Adisa – was controlled by Russian oil magnate Viktor Artemov and was engaged in an oil smuggling network.

    Attorney General Pam Bondi released a video of the seizure on X.

    So the latest U.S. seizure was, on the surface, unrelated to the sanctions placed on Venezuela by U.S. authorities in 2019 and expanded in 2020 to include secondary sanctions – that is, on countries that do business on the targeted nation or company.

    As such, Venezuelan officials have said this is unprecedented. And they are largely right. While there have been a few occasions in which Iranian tankers have been seized due to sanctions busting, this is the first time that there has been a seizure of a vessel departing Venezuela and with a Venezuelan crew.

    The Trump administration has signaled that it is not only seizing the cargo but the ship itself – which would represent a significant loss for the company owning the ship. The loss will be borne by the company, not Venezuela, as it was under a “Free on Board” contract, meaning that as soon as it left Venezuela the buyer takes responsibility for it.

    Nonetheless, this is a significant escalation of the pressure campaign on Venezuela, which looks set to continue. Reuters has reported that around 30 other tankers near Venezuela have some kind of sanction against them. They form part of a large shadow fleet that try to skirt sanctions through hiding their identity while transporting oil from Russia, Venezuela and Iran.

    The signal from U.S. officials is that they are prepared to go after more vessels and further squeeze Venezuela’s oil revenues through fresh sanctions.

    How often they will seize vessels is not known, but the clear threat from the White House is that the U.S. will continue with this seizure campaign.

    How important are oil exports to Venezuela?

    Venezuela’s economy is tremendously dependent on oil production.

    We do not have exact figures, as the Venezuela government has not published them in seven years, but most analysts believe oil constitutes north of 80% of all of the country’s exports – some even put this figure above 90%.

    Most of that oil goes to the black market, and a majority ends up with independent refiners in China. State-owned enterprises in China tend not to buy this oil because they do not want to fall foul of the sanctions regime. But Beijing tends to turn a blind eye to tankers heading to non-state entities, especially if those tankers have hidden their true identity so it doesn’t look like they are coming from Venezuela.

    Oil production makes up a large chunk of Venezuela’s economy.
    Federico Parra/AFP via Getty Images

    Around 80% of Venezuelan oil goes to China in this way; around 17% goes to the U.S. through a license awarded by the U.S. Treasury to oil giant Chevron. And 3% goes to Cuba, which tends to be subsidized by the Venezuelan government.

    Venezuela’s economy itself is also very dependent on oil, with the sector making up about 20% of total GDP, more than any other industry. And when it comes to government income, the oil sector makes up north of 50%.

    How have US actions affected Venezuelan oil production?

    It is important to know that even before U.S. sanctions began in 2019, Venezuela’s oil production was in severe decline.

    In 1998, before Hugo Chávez, the leftist military officer who became a populist president, came to power, oil production peaked at around 3.4 million barrels a day. By the time Chávez died and Maduro succeeded him in 2013, it had fallen to 2.7 million barrels a day.

    When U.S. sanctions targeting the state-owned oil company, Petróleos de Venezuela, were enacted in 2019, production was down to 1.3 million barrels a day – but that had already been affected by the other financial sanctions that came in two years earlier.

    The oil sanctions of 2019 closed the U.S. market, taking away half a million barrels a day that at the time headed from Venezuela to the U.S. As a result, Venezuela had to increase oil sales to India and China.

    But then the 2020 secondary sanctions, which apply to countries doing business with Venezuela, came in. As a result, Europe and India stopped buying Venezuelan oil, meaning that its only markets were Cuba and China. Of course, that year also saw the onset of the COVID-19 pandemic, which resulted in a massive cooling of the oil market globally.

    Venezuelan oil production collapsed to 400,000 barrels a day that year. Today it has recovered to around 1 million barrels a day. This has been helped by the U.S. allowing Chevron – which, after Petróleos de Venezuela, is the second-largest oil company operating in the country – to continue production.

    How does Venezuela get around oil sanctions?

    Venezuela relies on a shadow fleet to help it skirt U.S. sanctions. These vessels hide their identity by using false flags and false names.

    Companies often take a tanker that is going to be retired and change the identity, put on a new coat of paint and make sure transponders – devices that transmit radio signals to give a map reading – are doctored so that it looks like the ship is in a different place altogether.

    These ships arrive in Venezuela, pick up oil and then set sail. Sometimes they then transfer the cargo to another ship – which carries huge environmental risks. And then it arrives typically in Malaysia, where it takes on a Malaysian identity and on it goes to China.

    What impact has this latest seizure had on the price of oil?

    The seizure had little impact on global oil prices, because of exiting oversupply and due to the fact that Venezuela makes up only around 1% of the overall market. That could change, depending on how aggressive the U.S. gets. But the Trump administration will be mindful that it doesn’t want to see domestic prices rise as a result.

    A man in white stands in the center of a large crowd.
    Venezuelan leader Nicolás Maduro faces growing pressure over his country’s economic problems.
    Pedro Rances Mattey/Anadolu via Getty Images

    As to the price of Venezuelan oil, that could be more drastic. Venezuelan oil is already sold at a discount on the black market because of the existing risk relating to the sanctions. This latest action is likely to widen these discounts even further.

    In addition, Venezuela has until now required companies to pay some of the payment for oil cargo upfront – and a lot will be unwilling to do so now, due to high costs involved in a U.S. seizure. For example, a tanker of 2 million barrels, even with the current discount, will be worth around US$100 millon – no one wants to risk that much money. So very few buyers will be willing to prepay. Instead they will expect Venezuela to share the risk.

    The bottom line for Maduro is that the only way to get someone to buy Venezuelan oil amid the heightened risk of this moment is to offer higher discounts with fewer prepayments. Besides discounts, export volumes could also be affected and that in turn would lead to production cuts, which are costly to reverse.

    And all this will further choke off the already limited revenue that Maduro is relying on to keep Venezuela’s government functioning.

    Continue Reading

  • Asian Stocks Jump After Global Gauge Hits New Peak: Markets Wrap

    Asian Stocks Jump After Global Gauge Hits New Peak: Markets Wrap

    (Bloomberg) — Asian stocks rallied after gauges of US and global equities hit fresh records, with sentiment boosted by this week’s Federal Reserve’s rate cut and its upbeat assessment of the US economy.

    MSCI Inc.’s index of Asian shares was up 0.9% on Friday, poised for its highest close in about a month. Japan’s Topix led regional gains, with financials favored on bets that a Bank of Japan interest-rate hike next week is all but certain. Chinese equities underperformed after the nation’s leadership signaled it will maintain economic support but refrain from ramping up stimulus next year.

    While the S&P 500 climbed 0.2% to an all-time high on Thursday, some caution for tech names persisted. Shares of Broadcom Inc., a chip company vying with Nvidia Corp. for AI computing revenue, slid in late trading after its sales outlook for red-hot market failed to meet investors’ lofty expectations. S&P 500 futures were steady on Friday though contracts on the tech-heavy Nasdaq 100 fell 0.1%.

    Thursday’s price action lifted the MSCI All Country World Index — one of the broadest measures of the stock market — to a new closing high. Up nearly 21% in 2025, it is on track for its best year since 2019.

    “The momentum should continue into year-end. With rate cuts underway, a new Fed chair on deck, and earnings trending higher, the bull market looks positioned to extend into 2026,” said Gina Bolvin, President of Bolvin Wealth Management Group. “As more companies adopt AI, participation should broaden and sectors beyond the Magnificent Seven may start to show strength.”

    Delivering a third consecutive interest-rate reduction on Wednesday, Fed Chair Jerome Powell voiced optimism that the US economy will strengthen as the inflationary impact from tariffs fades away. While officials maintained their outlook for just one cut in 2026, traders have stuck to bets for two such moves.

    The Fed now expects the US economy to grow by 2.3% next year, up from its previous projection of 1.8%, while anticipating that the pace of inflation will slow to 2.4%.

    An index of the dollar traded around a two-month low on Friday and was on track for a third weekly loss. Yields on 10-year Treasuries were little changed after a small gain on Thursday, when data showed that initial jobless claims rose more than expected in the Dec. 6 week.

    “The Fed’s ‘hawkish-but-bullish’ cut last night reinforces this: stronger 2026 growth, faster disinflation,” said Florian Ielpo, head of macro at Lombard Odier Investment Managers. “Cuts are continuing, but they’re no longer automatic — and that’s usually a constructive backdrop for equities.”

    In Asia, Thailand markets were in focus after Prime Minister Anutin Charnvirakul moved to dissolve parliament, setting the stage for an early election after reports of a key political party backing his minority government moving to withdraw its support.

    Elsewhere, copper climbed to a fresh record high on Thursday and most other industrial metals rose after the Fed move. Gold steadied after three days of gains, supported by the prospect of further monetary easing in the US, while silver traded near a record high. Oil rallied from its lowest close in almost two months and Bitcoin flip-flopped in a tight range around $92,500.

    The tech sector continues to be on traders’ radar after dominating much of the recent market action following Oracle Corp.’s results — which brought worries about valuations and whether heavy spending on AI infrastructure will pay off back into focus.

    “The effect of Oracle has been greater than the Fed. This already tells us everything as we’ve been witnessing a strong concentration and one theme — AI — leading the market,” said Alberto Tocchio, a portfolio manager at Kairos Partners. “This doesn’t mean that AI is gone or it’s a bubble, but we need to focus on a wider scale.”

    Corporate News

    SoftBank Group Corp. is studying potential acquisitions including data center operator Switch Inc., as billionaire founder Masayoshi Son ramps up the search for deals that can help it ride the AI-fueled boom in digital infrastructure, people with knowledge of the matter said. Walt Disney Co. is licensing iconic characters including Mickey Mouse and Cinderella to OpenAI for use on its artificial intelligence video platform and has agreed to take a $1 billion stake in the startup. Huawei Technologies Co. and manufacturing partner Semiconductor Manufacturing International Corp. are making advances in chip production technology despite US attempts to limit their progress, according to analysis of a new phone’s components by research firm TechInsights. China’s internet search leader Baidu Inc. is seeing a fresh wave of bullish calls from analysts thanks to the possible listing of its chip unit Kunlunxin. OpenAI is rolling out a new artificial intelligence model designed to make ChatGPT better at coding, science and a wide range of work tasks, weeks after Alphabet Inc.’s Google put the startup on defense with the well-received launch of Gemini 3. Sembcorp Industries Ltd. agreed to buy Australian power generator and retailer Alinta Energy Pty for A$6.5 billion ($4.3 billion) in enterprise value, furthering the Singaporean company’s ambitions to expand outside its home market. Some of the main moves in markets:

    Stocks

    S&P 500 futures were little changed as of 11:30 a.m. Tokyo time Japan’s Topix rose 1.6% Australia’s S&P/ASX 200 rose 1.2% Hong Kong’s Hang Seng rose 1% The Shanghai Composite fell 0.4% Euro Stoxx 50 futures rose 0.3% Currencies

    The Bloomberg Dollar Spot Index was little changed The euro was little changed at $1.1734 The Japanese yen was little changed at 155.70 per dollar The offshore yuan was little changed at 7.0536 per dollar Cryptocurrencies

    Bitcoin fell 0.5% to $92,380.85 Ether was little changed at $3,248.42 Bonds

    The yield on 10-year Treasuries was little changed at 4.15% Australia’s 10-year yield was little changed at 4.72% Commodities

    West Texas Intermediate crude rose 0.7% to $58.02 a barrel Spot gold fell 0.1% to $4,275.28 an ounce This story was produced with the assistance of Bloomberg Automation.

    –With assistance from Joanna Ossinger and Richard Henderson.

    ©2025 Bloomberg L.P.

    Continue Reading

  • Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab

    HONG KONG, Dec. 11, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody. The study will compare cadonilimab plus chemotherapy against chemotherapy with or without nivolumab as first-line treatment for HER2-negative, unresectable or metastatic gastric/gastroesophageal junction adenocarcinoma.

    This is the second international registrational study for cadonilimab, following the ongoing trial in immunotherapy-resistant hepatocellular carcinoma. COMPASSION-37 represents a pivotal advancement in cadonilimab’s global development and a concrete step in Akeso’s worldwide strategy, reinforcing its leadership in next-generation immuno-oncology. The company remains committed to its dual-track approach of proprietary development and strategic collaboration, leveraging global resources to accelerate cadonilimab’s international availability and expand accessible treatment options for patients worldwide.

    Chemotherapy with or without PD-1 inhibitors, such as nivolumab, represents the international standard of care for advanced gastric cancer. However, the disease exhibits significant heterogeneity. While PD-1 treatment in combination with chemotherapy remains an effective treatment in many gastric cancer patients with high PD-L1 expression (CPS >5), its efficacy is markedly limited in gastric cancer patients with low PD-L1 expression (CPS <5) or negative PD-L1 expression (CPS <1). These low and negative PD-L1 patients constitute well more than half of the total gastric cancer patient population.

    In 2024, the FDA narrowed the indication for all approved PD-1 inhibitors in the first-line treatment of advanced gastric cancer, restricting their use to PD-L1-positive patients. Authoritative guidelines, including those from the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO), also prioritize recommending nivolumab-based regimens for patients with PD-L1 CPS ≥5. This underscores that treating advanced gastric cancer in PD-L1 low-expressing and negative patients has become a globally recognized clinical challenge.

    In 2024, based on the COMPASSION-15 study results, cadonilimab in combination with chemotherapy was approved in China for the first-line treatment of gastric cancer, demonstrating benefit across all patient populations, including both PD-L1 positive and negative subgroups.

    COMPASSION-15 is the only global Phase III clinical study in first-line advanced gastric cancer to have demonstrated survival benefit across all patient populations, irrespective of PD-L1 expression status. In this trial, patients with low PD-L1 expression and those who were PD-L1-negative accounted for as high as 49.8% and 23% of the enrolled population, respectively, significantly exceeding proportions observed in historical studies of its kind. The robust representation of low and negative PD-L1 patients in the study and the effective treatment of these patients validates cadonilimab’s broad-spectrum antitumor efficacy beyond PD-L1 dependency in gastric cancer.

    Long-term follow-up data showed that cadonilimab plus chemotherapy significantly reduced the risk of death by 39% in the overall population compared to the control group (OS HR 0.61), regardless of PD-L1 status. In the PD-L1 CPS ≥5 subgroup, the reduction in mortality risk reached 51% (OS HR 0.49). Importantly, even among patients with low PD-L1 expression (CPS <5), a statistically significant 24% reduction in mortality risk was maintained (OS HR 0.76). These results were presented as an oral report at ESMO 2025. Earlier interim analysis data from the COMPASSION-15 study had been released as a prominent oral presentation at AACR 2024, with the full manuscript subsequently published in the Nature Medicine. These results highlight cadonilimab’s potential to elevate the current standard of tumor immunotherapy and address clinical challenges unmet by single-target agents.

    Forward-Looking Statement of Akeso, Inc.

    This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

    Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

    Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

    About Akeso

    Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has created a unique integrated R&D innovation system with the comprehensive end-to-end drug development platform (ACE Platform) and bi-specific antibody drug development technology (Tetrabody) as the core, a GMP-compliant manufacturing system and a commercialization system with an advanced operation mode, and has gradually developed into a globally competitive biopharmaceutical company focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 26 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

    For more information, please visit https://www.akesobio.com/en/about-us/corporate-profile/ and follow us on Linkedin.

    SOURCE Akeso, Inc.

    Continue Reading

  • Apple wins partial reversal of sanctions in Epic Games antitrust lawsuit – Reuters

    1. Apple wins partial reversal of sanctions in Epic Games antitrust lawsuit  Reuters
    2. Tim Sweeney on the future of Fortnite after another win over Apple  The Verge
    3. Apple loses court appeal in App Store case against Epic  Tech in Asia
    4. Appeals Court Says Judge Must Consider Allowing Apple to Collect Commission  PYMNTS.com
    5. Apple (mostly) loses its appeal in Epic Games case  Engadget

    Continue Reading

  • Chinese shares open mixed Friday – Xinhua

    1. Chinese shares open mixed Friday  Xinhua
    2. China stocks end lower after Fed rate cut  Business Recorder
    3. The Shangai Composite Index Closes 0.76% Lower  TradingView
    4. Shanghai Composite Falls 0.76% Amid 0.17x Advance/Decline Ratio; Great Microwave Soars 17.4%  Markets Mojo
    5. Chinese Shares Dip Amid Deflation; Vanke Boosts Property Stocks  Devdiscourse

    Continue Reading

  • Honda to Launch New Heritage Service Business — “Honda Heritage Works” — in April 2026

    Honda to Launch New Heritage Service Business — “Honda Heritage Works” — in April 2026

    TOKYO, Japan, December 12, 2025 – Honda Motor Co., Ltd. today announced plans to launch Honda Heritage Works, a new heritage service business for classic Honda (and Acura) sport-type models, on April 1, 2026. For customers who cherish and wish to continue driving their beloved vehicles for many years, Honda will offer reproduction parts on a global basis to replace discontinued parts, as well as a restoration service in Japan.

    Honda Heritage Works will consist of two services: Honda Heritage Parts, which reproduces and supplies certain discontinued genuine parts no longer in mass production, and Honda Restoration Service, a new service to be offered in Japan to restore customer vehicles utilizing the reproduced parts. Both will start with the first-generation NSX, with plans to expand to other classic sport-type models in the future.

    Ahead of the service launch in April 2026, Honda today launched the official Honda Heritage Works website. Detailed information, including pricing and service offerings, will be released sequentially leading up to the start of the service.

    Official Honda Heritage Works website URL:
    https://www.honda.co.jp/heritage-works/ (Japanese)

    Continue Reading

  • Honda to Launch New Heritage Service Business — “Honda Heritage Works” — in April 2026

    Honda to Launch New Heritage Service Business — “Honda Heritage Works” — in April 2026

    TOKYO, Japan, December 12, 2025 – Honda Motor Co., Ltd. today announced plans to launch Honda Heritage Works, a new heritage service business for classic Honda (and Acura) sport-type models, on April 1, 2026. For customers who cherish and wish to continue driving their beloved vehicles for many years, Honda will offer reproduction parts on a global basis to replace discontinued parts, as well as a restoration service in Japan.

    Honda Heritage Works will consist of two services: Honda Heritage Parts, which reproduces and supplies certain discontinued genuine parts no longer in mass production, and Honda Restoration Service, a new service to be offered in Japan to restore customer vehicles utilizing the reproduced parts. Both will start with the first-generation NSX, with plans to expand to other classic sport-type models in the future.

    Ahead of the service launch in April 2026, Honda today launched the official Honda Heritage Works website. Detailed information, including pricing and service offerings, will be released sequentially leading up to the start of the service.

    Official Honda Heritage Works website URL:
    https://www.honda.co.jp/heritage-works/ (Japanese)

    Continue Reading

  • Trump orders increased scrutiny of proxy advisers ISS and Glass Lewis

    Trump orders increased scrutiny of proxy advisers ISS and Glass Lewis

    Unlock the White House Watch newsletter for free

    US President Donald Trump has signed an executive order to “increase oversight” of powerful proxy advisers that guide shareholder votes made by pension funds and some other money managers.

    Trump directed the Securities and Exchange Commission, the Federal Trade Commission and the Department of Labor to step up regulation of two dominant advisory groups.

    The order said Glass Lewis and Institutional Shareholder Services “regularly use their substantial power to advance and prioritize radical politically-motivated agendas”, citing their past support for environmental and diversity initiatives.

    ISS’ and Glass Lewis’s recommendations, which wield huge influence in companies’ shareholder votes, have angered powerful chief executives such as Jamie Dimon and Elon Musk.

    The order directs the SEC to examine if ISS and Glass Lewis have violated anti-fraud statutes in their recommendations or should be regulated as investment advisers.

    The FTC, the federal competition watchdog, is directed to review “ongoing State antitrust investigations” to determine if the proxy companies may have violated federal competition laws.

    The labour department, meanwhile, is set to determine if pension plans that it regulates can use proxy advisers, given the pensions’ fiduciary duty obligations.

    The White House said proxy groups’ support for diversity and environmental proposals was unrelated to maximising investment returns, which “should be the only priority”.

    ISS said it would review the order. “ISS does not dictate or set corporate governance standards and remains firmly committed to operating professionally, ethically, independently and in the best interests of our clients, as we have done historically,” it said.

    Glass Lewis did not immediately respond.

    The two groups have challenged a new Texas state law that imposed onerous disclosure requirements on proxy advisers’ recommendations. They argue Texas has violated their free speech rights.

    Glass Lewis, recognising the broader political pressure it was facing, in October said it would move away from “house” recommendations, the default preferences on governance matters that it published each year.

    Continue Reading

  • Johanna Cardoso ’26 is Studying Abroad to ‘Fashion’ her Professional Journey

    Johanna Cardoso ’26 is Studying Abroad to ‘Fashion’ her Professional Journey

    Johanna Cardoso ’26 is a fashion enthusiast. And in spring 2025, she set out to define her style — and her career — in one of the Big Four fashion capitals of the world: Milan, Italy. During her semester abroad at MKS Milano Fashion School, she stepped into the role of a professional stylist with access to a glam squad (team of beauty experts) and a designer showroom. A bonus: the chance to attend a show at Milan Fashion Week. 

    “Being in Milan during Fashion Week was an unforgettable experience,” Cardoso says of an invitation from a professor who works in the fashion business. “From witnessing the fast-paced energy of the industry firsthand to getting involved behind the scenes, I gained a deeper appreciation for the craftsmanship, creativity and strategy that go into building fashion moments.” 

    In Milan, Cardoso took courses in styling and merchandising, building on what she’s learning at Bentley. “The full experience of Fashion Week has reaffirmed my passion for visual storytelling, brand experiences, and consumer engagement — skills I’ve been developing through my studies as a double major in Marketing and Experience Design.” 

    For a final class project, Cardoso led an editorial photoshoot from concept to completion: casting a model, selecting pieces from a local designer’s archival collections, and developing the creative vision through mood boards. She managed all the details — from hair and makeup to posing and artistic direction. “Seeing how brands create immersive, high-impact fashion experiences has been inspiring, and I can’t wait to bring these insights into my future work,” Cardoso says. 

    Continue Reading

  • ANZ to defend itself against former CEO's legal claim on $9 million bonus cut – Reuters

    1. ANZ to defend itself against former CEO’s legal claim on $9 million bonus cut  Reuters
    2. Former ANZ boss launches legal action over $13.5 million in lost bonuses  WAtoday
    3. ANZ Comments On Former CEO’s Legal Action  Mirage News
    4. Ex-ANZ boss launches legal action against bank for bonus cut  The Nightly
    5. Ex-ANZ boss launches legal claim against bank for bonus cull  The Australian

    Continue Reading